Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
The Lancet
4mon

Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial

Copyright: © 2025 The Author(s). Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Says he will sue Trump
Sentenced to over 4 years
Texas shooting
Vows to 'do better'
Shutters all stores
Montgomery mass shooting
Booked into Georgia jail
Cracker Barrel drops firm
First supermoon of 2025
Former NFL star dies
FBI cuts ties with SPLC
Signs crime bill into law
Trump: Stop bombing Gaza
'Vice Principals' star dies
Would-be assassin sentenced
Russian drones hit UKR
LA City Hall evacuated
Sued by former executive
Shooting forces lockdown
Czech author Klíma dies
Wins request for hearing
Bezos on AI bubble
Protester shot in Chicago
Typhoon Matmo hits China
To send troops to Chicago
Israel strikes Gaza
Nissan to recall US vehicles
Signs deal for driver unions
Syria holds elections
Kicks off ‘SNL’ 51st season
Reveals WH UFC fight date
Named as Rangers’ manager
Exits game after collision
OPEC+ to raise oil production
Floods, landslides in Nepal
Feedback
  • Privacy
  • Terms